Siloxane nanoparticles unlock precise organ targeting for mRNA therapy

Siloxane nanoparticles unlock precise organ targeting for mRNA therapy - EurekAlert

Personalized Melanoma Vaccine Could Be a ‘Game Changer’ by Teaching the Body to Fight Cancer Cells. The mRNA therapy, designed to prevent treated skin cancer from returning, is entering its third phase of trials.